Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir/Ledipasvir in Adolescents with Chronic HCV
NCT03343444Phase 3Unknown
- Sponsor
- Egyptian Liver Hospital
- Start
- Apr 2017
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sofosbuvir, ledipasvir in hepatitis C (HCV), sponsored by Egyptian Liver Hospital. Status: unknown.
02
Drugs
sofosbuvirledipasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03343444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03343444.